Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
2001 1
2002 1
2003 2
2004 1
2009 3
2010 1
2011 6
2012 1
2013 2
2014 5
2015 5
2016 2
2017 2
2018 1
2019 5
2020 2
2021 5
2022 8
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T; SUSTAIN-6 Investigators. Marso SP, et al. N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141. Epub 2016 Sep 15. N Engl J Med. 2016. PMID: 27633186 Free article. Clinical Trial.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators. Scirica BM, et al. N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2. N Engl J Med. 2013. PMID: 23992601 Free article. Clinical Trial.
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial.
Pieber TR, Bode B, Mertens A, Cho YM, Christiansen E, Hertz CL, Wallenstein SOR, Buse JB; PIONEER 7 investigators. Pieber TR, et al. Lancet Diabetes Endocrinol. 2019 Jul;7(7):528-539. doi: 10.1016/S2213-8587(19)30194-9. Epub 2019 Jun 9. Lancet Diabetes Endocrinol. 2019. PMID: 31189520 Clinical Trial.
Vitamin D and Type 2 Diabetes Mellitus.
Issa CM. Issa CM. Adv Exp Med Biol. 2017;996:193-205. doi: 10.1007/978-3-319-56017-5_16. Adv Exp Med Biol. 2017. PMID: 29124701 Review.
Rising syphilis rates in Canada, 2011-2020.
Aho J, Lybeck C, Tetteh A, Issa C, Kouyoumdjian F, Wong J, Anderson A, Popovic N. Aho J, et al. Among authors: issa c. Can Commun Dis Rep. 2022 Feb 24;48(23):52-60. doi: 10.14745/ccdr.v48i23a01. eCollection 2022 Feb 24. Can Commun Dis Rep. 2022. PMID: 35341093 Free PMC article.
Vitamin D replacement and type 2 diabetes mellitus.
Issa CM, Zantout MS, Azar ST. Issa CM, et al. Curr Diabetes Rev. 2015;11(1):7-16. doi: 10.2174/1573399811666141210153503. Curr Diabetes Rev. 2015. PMID: 25495839 Review.
Flexural capacity of eco-friendly reinforced concrete beams.
Gerges NN, Issa CA, Khalil NJ, Abdul Khalek L, Abdo S, Abdulwahab Y. Gerges NN, et al. Among authors: issa ca. Sci Rep. 2023 Nov 17;13(1):20142. doi: 10.1038/s41598-023-47283-6. Sci Rep. 2023. PMID: 37978199 Free PMC article.
56 results